{"id":"W2094241860","doi":"10.1056/nejmoa1215541","title":"Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection","year":2013,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":878,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network","funders":"","keywords":"Dolutegravir; Abacavir; Medicine; Lamivudine; Virology; Integrase inhibitor; Regimen; Human immunodeficiency virus (HIV); Antiretroviral therapy; Virus; Internal medicine; Viral load; Hepatitis B virus","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007674844,0.0002734626,0.0008816041,0.0002067471,0.0002125768,0.0002300867,0.0003604045,0.0002888418,0.004365552],"category_scores_gemma":[0.0006602441,0.0001444636,0.0003867956,0.0002320249,0.0002495183,0.0001976381,0.0002150054,0.0007408642,0.000418354],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000361937,"about_ca_system_score_gemma":0.0006945897,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004929007,"about_ca_topic_score_gemma":0.001763286,"domain_scores_codex":[0.9997063,0.0001374142,0.00002992658,0.0000414928,0.00005082393,0.00003401047],"domain_scores_gemma":[0.999826,0.00005180769,0.00003701978,0.00001016586,0.00001244357,0.00006254316],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3008948,0.01423928,0.01562147,0.004315915,0.001620243,0.0003786941,0.0002714682,0.002182381,0.03537667,0.0006068858,0.006051465,0.6184406],"study_design_scores_gemma":[0.5540404,0.2972127,0.08749681,0.0008807546,0.001643955,0.002757803,0.0001759702,0.002914776,0.009721179,0.001007188,0.04208947,0.00005881866],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9667012,0.02191109,0.001139233,0.0008372685,0.0001861667,0.002583706,0.00104727,0.00009447047,0.005499588],"genre_scores_gemma":[0.9870908,0.006002839,0.00261744,0.0007102445,0.0001799211,0.0009971035,0.0005459408,0.000008031586,0.001847708],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004365552,"threshold_uncertainty_score":0.01460427,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02589605435681262,"score_gpt":0.2881361588825451,"score_spread":0.2622401045257324,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}